1. Innovation or stagnation? challenge and opportunity on the critical path to new medical products, FDA Report,2004
2. Rebuilding the R&D Engine in Big Pharma, Harvard Business Review;Garnie,2008
3. A more rational approach to new-product development. Harvard Business Review;Bonabeau,2008
4. Reducing the time to develop and manufacture formulations for first oral dose in humans;Hariharan;Pharm Tech,2003
5. Designing a molecular delivery system within a preclinical timeframe;Henck;Drug Discov Today,2007